A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of offâtherapy relapse: An observational study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.15966
Abstract: In HBeAg negative chronic hepatitis B (CHB) patients, clinical relapse (CR) occurs more frequently, much earlier and often more severely after stopping tenofovir (TDF) and other nucleos(t)ide analogues (Nucs) than after stopping entecavir (ETV). It… read more here.
Keywords: relapse; tenofovir entecavir; switch tenofovir; hepatitis ... See more keywords
Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Molecular Hepatology"
DOI: 10.3350/cmh.2020.0099
Abstract: Corresponding author : Byoung Kuk Jang Department of Internal Medicine, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu 42601, Korea Tel: +82-53-258-7720, Fax: +82-53-258-4343 E-mail: [email protected] https://orcid.org/0000-0002-8950-0866 Abbreviations: ADV, adefovir dipivoxil; CHB, chronic hepatitis… read more here.
Keywords: medicine; tenofovir entecavir; response; hepatitis ... See more keywords
Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis
Sign Up to like & getrecommendations! Published in 2019 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v25.i23.2961
Abstract: BACKGROUND Recently, the American Association for the Study of Liver Disease suggested no preference between tenofovir (TDF) and entecavir (ETV) regarding potential long-term risks of renal complications. Over the years, renal safety has become a… read more here.
Keywords: tenofovir entecavir; review meta; renal safety; systematic review ... See more keywords